NCT02521493 2025-08-01Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down SyndromeChildren's Oncology GroupPhase 3 Active not recruiting280 enrolled 13 charts